NEW YORK (Reuters Health) - Among men with good sexual function before treatment with low-dose brachytherapy for prostate cancer, erectile function is likely to remain good over the long term, ...

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...

Pelvic clinical node-positive prostate cancer: Impact of radiotherapy and nodal disease burden. Validation of baseline health-related quality of life as prognostic indicator for survival outcome in ...

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer Men with prostate cancer stage cT1c-T2bN0M0, ...

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no ...

When Chris Muraithi, turned 45, he started going for regular tests to check his prostate. One of the tests performed during his visits to a medical facility is one that measures the level of ...

Answer: About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, making it one of the most diagnosed ...

Brachytherapy-based regimens appear to be effective salvage treatment for localized radiorecurrent prostate cancer, investigators reported at the 2024 ASCO Genitourinary Cancers Symposium in San ...

The 15-year OS rate was 60% among prostate brachytherapy recipients and 55% among EBRT recipients, indicating no significant difference between the arms. In prostate cancer, prostate brachytherapy (PB ...

Overall, 30 months of adjuvant androgen deprivation therapy (ADT) did not improve biochemical control and other survival endpoints compared with just 6 months of ADT in men with high-risk localized ...